Clinical Trial Detail

NCT ID NCT02788981
Title Abraxane With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

triple-receptor negative breast cancer

Therapies

Mifepristone + Nab-paclitaxel

Nab-paclitaxel

Age Groups: adult senior

No variant requirements are available.